Literature DB >> 2416952

Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins.

G A Bishop, G Kümel, S A Schwartz, J C Glorioso.   

Abstract

The frequency and specificity of human cells with natural killer (NK) cytotoxic activity for herpes simplex virus type 1 (HSV-1)-infected targets was measured by limiting dilution culture. The frequency of NK cell precursors (NK-p) reactive with HSV-1-infected cells was 2- to 11-fold higher than that of NK-p reactive with mock-infected cells. The frequency of NK-p reactive with infected target cells lacking viral glycoprotein C or presenting an antigenically altered glycoprotein B was approximately twofold lower than that with wild-type virus-infected cells. Specificity analysis demonstrated that NK cells with a high statistical probability of being monoclonal were reactive with either glycoprotein B or C. These results provide the first evidence that cells with human NK activity possess clonal specificity for HSV-1-infected target cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2416952      PMCID: PMC252726     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Target-effector interaction in the natural killer cell system: isolation of target structures.

Authors:  J C Roder; A Rosén; E M Fenyö; F A Troy
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

2.  Specificities in natural cell-mediated cytotoxicity by the cross-competition assay.

Authors:  M Takasugi; D Koide; A Ramseyer
Journal:  Int J Cancer       Date:  1977-03-15       Impact factor: 7.396

3.  Separation of mouse spleen cells by passage through columns of sephadex G-10.

Authors:  I A Ly; R I Mishell
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins.

Authors:  T C Holland; F L Homa; S D Marlin; M Levine; J Glorioso
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.

Authors:  R J van de Griend; B A van Krimpen; C P Ronteltap; R L Bolhuis
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

7.  Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis.

Authors:  J C Glorioso; M Levine; T C Holland; M S Szczesiul
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

Review 8.  Heterogeneity of natural killer cells.

Authors:  J R Ortaldo; R B Herberman
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

9.  Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody.

Authors:  C Ching; C Lopez
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

10.  Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte.

Authors:  D Santoli; G Trinchieri; F S Lief
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

View more
  15 in total

1.  Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.

Authors:  M Gong; T Ooka; T Matsuo; E Kieff
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

2.  Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.

Authors:  S L Highlander; S L Sutherland; P J Gage; D C Johnson; M Levine; J C Glorioso
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

3.  Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.

Authors:  S L Highlander; W H Cai; S Person; M Levine; J C Glorioso
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

4.  Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC-binding sites and demonstration of conserved C3b binding in low-passage clinical isolates.

Authors:  H M Friedman; J C Glorioso; G H Cohen; J C Hastings; S L Harris; R J Eisenberg
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

5.  Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses.

Authors:  Giulia Fulci; Laura Breymann; Davide Gianni; Kazuhiko Kurozomi; Sarah S Rhee; Jianhua Yu; Balveen Kaur; David N Louis; Ralph Weissleder; Michael A Caligiuri; E Antonio Chiocca
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

6.  Heterogeneity amongst natural killer cells revealed by limiting dilution culture; selectivity against virus-infected and tumour cell targets.

Authors:  P D Mason; J G Sissons; L K Borysiewicz
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

7.  Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L.

Authors:  H Ghiasi; R Kaiwar; S Slanina; A B Nesburn; S L Wechsler
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  A comparison of T cell responses to glycoprotein B (gB-1) of herpes simplex virus type 1 and its non-glycosylated precursor protein, pgB-1.

Authors:  C A O'Donnell; W L Chan
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Increased adherence of human granulocytes to herpes simplex virus type 1 infected endothelial cells.

Authors:  B A Zajac; K O'Neill; H M Friedman; R R MacGregor
Journal:  In Vitro Cell Dev Biol       Date:  1988-04

10.  Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.

Authors:  M Niikura; Y Matsuura; D Endoh; M Onuma; T Mikami
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.